-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PO5yPbigprptlHo2zAdn0cUzKmJQ2se7BuJ14sv9h/Xo+mYYO4Twy824lSPA2Yvr wbNIuT5qBQmNHgzPJbwgzw== 0001470274-10-000002.txt : 20100520 0001470274-10-000002.hdr.sgml : 20100520 20100519203727 ACCESSION NUMBER: 0001470274-10-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100520 DATE AS OF CHANGE: 20100519 EFFECTIVENESS DATE: 20100520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: On Demand Therapeutics, Inc. CENTRAL INDEX KEY: 0001470274 IRS NUMBER: 263425852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-142318 FILM NUMBER: 10846523 BUSINESS ADDRESS: STREET 1: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: (650) 854-8585 MAIL ADDRESS: STREET 1: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 D 1 primary_doc.xml X0704 D LIVE 0001470274 On Demand Therapeutics, Inc. 2710 SAND HILL ROAD, 2ND FLOOR MENLO PARK CA CALIFORNIA 94025 (650) 854-8585 DELAWARE None None Corporation true 2008 John T. Santini, Jr. c/o On Demand Therapeutics, Inc. 2710 Sand Hill Road, 2nd Floor Menlo Park CA CALIFORNIA 94025 Executive Officer David Weber c/o On Demand Therapeutics, Inc. 2710 Sand Hill Road, 2nd Floor Menlo Park CA CALIFORNIA 94025 Director Gil Kliman c/o InterWest Partners X, L.P. 2710 Sand Hill Road, 2nd Floor Menlo Park CA CALIFORNIA 94025 Director Gordon Saul c/o On Demand Therapeutics, Inc. 2710 Sand Hill Road, 2nd Floor Menlo Park CA CALIFORNIA 94025 Executive Officer Biotechnology Decline to Disclose 06 false 2010-03-18 false true true true Convertible Promissory Notes and the underlying Preferred Stock issuable upon conversion of such Notes and the underlying Common Stock issuable upon conversion of such Preferred Stock. false 0 600000 300000 300000 false 1 0 0 0 false On Demand Therapeutics, Inc. /s/ John T. Santini, Jr. John T. Santini, Jr. President and CEO 2010-05-14 -----END PRIVACY-ENHANCED MESSAGE-----